DOI QR코드

DOI QR Code

Transcutaneous electrical nerve stimulation for pain during propofol injection: a randomized clinical trial

  • Dongwoo, Lee (Department of Oral and Maxillary surgery, School of Dentistry, Kyungpook National University) ;
  • Juhwa, Jin (Department of Anesthesiology and Pain Medicine, School of Medicine, Kyungpook National University) ;
  • Ji Hyo, Kim (Department of Anesthesiology and Pain Medicine, School of Medicine, Kyungpook National University) ;
  • Jinyoung, Oh (Department of Anesthesiology and Pain Medicine, School of Medicine, Kyungpook National University) ;
  • Younghoon, Jeon (Department of Oral and Maxillary surgery, School of Dentistry, Kyungpook National University)
  • Received : 2022.09.27
  • Accepted : 2022.10.27
  • Published : 2022.12.01

Abstract

Background: Propofol is a short-acting intravenous sedative widely used for procedural sedation and general anesthesia. However, pain during propofol injection is a distressing adverse effect. This study was designed to investigate whether transcutaneous electrical nerve stimulation (TENS) could reduce pain during propofol injection compared to sham TENS. Methods: In a randomized controlled trial, 80 patients were allocated to two groups: the active TENS group received electrical stimulation via two electrodes on the venous cannulation site, whereas the sham TENS group received no stimulus. After 20 min following TENS, propofol 0.5 mg/kg pain was injected intravenously and pain was evaluated using a four-point score (0 = none, 1 = mild, 2 = moderate, 3 = severe). Adverse effects associated with TENS were also recorded. Results: The overall incidence of pain during propofol injection was 47.5% in the TENS group and 87.5% in the sham group (P < 0.001). The incidence of moderate pain was significantly lower in the TENS group (7.5%) than in the sham TENS group (42.5%) (P < 0.001). There were no complications associated with TENS. Conclusion: Pre-treatment with TENS significantly reduced the incidence and intensity of pain during propofol injection.

Keywords

References

  1. Picard P, Tramer MR. Prevention of pain on injection with propofol: a quantitative systematic review. Anesth Analg 2000; 90: 963-9.
  2. Jalota L, Kalira V, George E, Shi YY, Hornuss C, Radke O, et al. Prevention of pain on injection of propofol: systematic review and meta-analysis. BMJ 2011; 342: d1110. https://doi.org/10.1136/bmj.d1110
  3. Jeon Y. Reduction of pain on injection of propofol: combination of nitroglycerin and lidocaine. J Anesth 2012; 26: 728-31. https://doi.org/10.1007/s00540-012-1394-6
  4. Yaksi E, Ketenci A, Baslo MB, Orhan EK. Does transcutaneous electrical nerve stimulation affect pain, neuropathic pain, and sympathetic skin responses in the treatment of chronic low back pain? A randomized, placebo-controlled study. Korean J Pain 2021; 34: 217-28. https://doi.org/10.3344/kjp.2021.34.2.217
  5. Johnson MI. Transcutaneous electrical nerve stimulation (TENS) as an adjunct for pain management in perioperative settings: a critical review. Expert Rev Neurother 2017; 17: 1013-27. https://doi.org/10.1080/14737175.2017.1364158
  6. Wu LC, Weng PW, Chen CH, Huang YY, Tsuang YH, Chiang CJ. Literature review and meta-analysis of transcutaneous electrical nerve stimulation in treating chronic back pain. Reg Anesth Pain Med 2018; 43: 425-33. https://doi.org/10.1097/aap.0000000000000740
  7. Mokhtari T, Ren Q, Li N, Wang F, Bi Y, Hu L. Transcutaneous electrical nerve stimulation in relieving neuropathic pain: basic mechanisms and clinical applications. Curr Pain Headache Rep 2020; 24: 14. https://doi.org/10.1007/s11916-020-0846-1
  8. Macario A, Weinger M, Truong P, Lee M. Which clinical anesthesia outcomes are both common and important to avoid? The perspective of a panel of expert anesthesiologists. Anesth Analg 1999; 88: 1085-91. https://doi.org/10.1213/00000539-199905000-00023
  9. Nakane M, Iwama H. A potential mechanism of propofol-induced pain on injection based on studies using nafamostat mesilate. Br J Anaesth 1999; 83: 397-404. https://doi.org/10.1093/bja/83.3.397
  10. Sluka KA, Walsh DM. Transcutaneous electrical nerve stimulation: basic science mechanisms and clinical effectiveness. J pain 2003; 4: 109-21. https://doi.org/10.1054/jpai.2003.434
  11. Johnson MI, Jones G. Transcutaneous electrical nerve stimulation: current status of evidence. Pain Manag 2017; 7: 1-4. https://doi.org/10.2217/pmt-2016-0030
  12. Johnson M. Transcutaneous Electrical Nerve Stimulation: mechanisms, clinical application and evidence. Rev Pain 2007; 1: 7-11. https://doi.org/10.1177/204946370700100103
  13. Gozani SN. Remote analgesic effects of conventional transcutaneous electrical nerve stimulation: a scientific and clinical review with a focus on chronic pain. J Pain Res 2019; 12: 3185-201. https://doi.org/10.2147/JPR.S226600
  14. Sluka KA, Bjordal JM, Marchand S, Rakel BA. What makes transcutaneous electrical nerve stimulation work? Making sense of the mixed results in the clinical literature. Phys Ther 2013; 93: 1397-402.
  15. Maeda Y, Lisi TL, Vance CG, Sluka KA. Release of GABA and activation of GABA (A) in the spinal cord mediates the effects of TENS in rats. Brain Res 2007; 1136: 43-50. https://doi.org/10.1016/j.brainres.2006.11.061
  16. Kim S, Park K, Son B, Jeon Y. The effect of transcutaneous electrical nerve stimulation on pain during venous cannulation. Curr Ther Res Clin Exp 2012; 73: 134-9. https://doi.org/10.1016/j.curtheres.2012.05.001
  17. Mohammadi O, Glassy MS, Cheung B, Shaikh U, Pezeshkian N. Inappropriate shock from a subcutaneous implantable cardioverter-defibrillator due to transcutaneous electrical nerve stimulation. Heart Rhythm 2015; 12: 1702-3. https://doi.org/10.1016/j.hrthm.2015.04.019
  18. Richardson C, Maciver K, Wright M, Wiles J. Patient reports of the effects and side-effects of TENS for chronic non-malignant pain following a four week trial. Pain Clin 2001; 13: 265-76. https://doi.org/10.1163/156856901753702447
  19. Schaub E, Kern C, Landau R. Pain on injection: a double-blind comparison of propofol with lidocaine pretreatment versus propofol formulated with long-and medium-chain triglycerides. Anesth Analg 2004; 99: 1699-702. https://doi.org/10.1213/01.ANE.0000136848.54207.97